We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
+12.92%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$488M
AUM Growth
+$7.56M
(+1.6%)
Cap. Flow
-$33.2M
Cap. Flow
% of AUM
-6.81%
Top 10 Holdings %
Top 10 Hldgs %
49.96%
Holding
83
New
39
Increased
11
Reduced
21
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$24.6M |
| 2 |
CVS Health
CVS
|
+$16.4M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
+$11.9M |
| 4 |
Bioventus
BVS
|
+$9.61M |
| 5 |
Henry Schein
HSIC
|
+$7.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$16.1M |
| 2 |
Perrigo
PRGO
|
+$15M |
| 3 |
United Therapeutics
UTHR
|
+$13.8M |
| 4 |
Pacira BioSciences
PCRX
|
+$13.2M |
| 5 |
AtriCure
ATRC
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.25% |
| 2 | Consumer Staples | 4.28% |
| 3 | Technology | 4.26% |
| 4 | Consumer Discretionary | 0.47% |
| 5 | Industrials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSON
26
DELISTED
Misonix Inc
MSON
| $6.86M | 1.41% |
350,000
+50,000
| +17% | +$835K |
|
|
MSACU
27
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
| $5.91M | 1.21% |
+600,000
| New | +$6.1M |
|
28
HCA Healthcare
HCA
$87.2B
| $5.65M | 1.16% |
+30,000
| New | +$5.29M |
|
29
Vertex Pharmaceuticals
VRTX
$121B
| $5.37M | 1.1% |
25,000
-17,000
| -40% | -$3.73M |
|
30
Talkspace
TALK
$874M
| $4.96M | 1.02% |
+500,000
| New | +$5.43M |
|
31
InMode
INMD
$870M
| $4.55M | 0.93% |
125,700
-54,300
| -30% | -$1.76M |
|
|
DMTK
32
DELISTED
DermTech, Inc. Common Stock
DMTK
| $4.27M | 0.88% |
84,000
+59,000
| +236% | +$3.09M |
|
33
UnitedHealth
UNH
$376B
| $3.72M | 0.76% |
+10,000
| New | +$3.47M |
|
|
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.55M | 0.73% |
575,000
-275,000
| -32% | -$1.67M |
|
35
Viatris
VTRS
$20.4B
| $3.49M | 0.72% |
250,000
-200,000
| -44% | -$3.26M |
|
36
Evolent Health
EVH
$348M
| $2.52M | 0.52% |
+125,000
| New | +$2.38M |
|
|
CALY
37
Callaway Golf Company
CALY
$3.32B
| $2.17M | 0.44% |
+81,000
| New | +$2.29M |
|
38
PUT
ARK Genomic Revolution ETF
ARKG
$1.55B
| $1.63M | 0.33% |
+3,000
| New | +$298K |
|
39
Xeris Biopharma Holdings
XERS
$1.39B
| $1.58M | 0.32% |
+350,000
| New | +$1.89M |
|
|
CMIIU
40
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| $1.28M | 0.26% |
+100,000
| New | +$1.26M |
|
|
41
Perrigo
PRGO
$1.4B
| $1.01M | 0.21% |
25,000
-350,000
| -93% | -$15M |
|
42
Cerus
CERS
$433M
| $902K | 0.19% |
+150,000
| New | +$1.02M |
|
43
CALL
Johnson & Johnson
JNJ
$618B
| $815K | 0.17% |
1,500
-2,500
| -63% | -$405K |
|
44
CALL
SPDR Gold Trust
GLD
$131B
| $788K | 0.16% |
8,000
+2,000
| +33% | +$336K |
|
|
OPTN
45
DELISTED
OptiNose
OPTN
| $646K | 0.13% |
11,667
-119,800
| -91% | -$7.29M |
|
46
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
| $643K | 0.13% |
+1,000
| New | +$148K |
|
|
AAT
47
American Assets Trust
AAT
$1.45B
| $389K | 0.08% |
+12,000
| New | +$371K |
|
48
Northrop Grumman
NOC
$77.1B
| $388K | 0.08% |
+1,200
| New | +$362K |
|
|
CTLT
49
PUT
DELISTED
CATALENT, INC.
CTLT
| $363K | 0.07% |
+250
| New | +$27.9K |
|
50
Calix
CALX
$2.26B
| $347K | 0.07% |
+10,000
| New | +$370K |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU
Tamarack Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Tamarack Advisers held 83 positions worth $488M, up 1.6% from $480M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Tamarack Advisers withdrew a net $33.2M in Q1 2021, closing 11 positions and reducing 21 holdings. Its most notable exit was Senior Connect Acquisition Corp. I Unit, an estimated $9.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Tamarack Advisers opened a new position in Patterson Companies, Inc. worth $24.6M.
- Tamarack Advisers's largest Q1 2021 buy was Patterson Companies, Inc.: 770,000 shares worth $24.6M.
- Tamarack Advisers added most to Luminex Corp in Q1 2021, an estimated $6.77M increase.
- Tamarack Advisers's biggest Q1 2021 reduction was Nuance Communications, Inc., cutting an estimated $16.1M.
- Tamarack Advisers fully exited Senior Connect Acquisition Corp. I Unit in Q1 2021, selling an estimated $9.84M.
- Tamarack Advisers's ten largest holdings make up 50% of its $488M portfolio in Q1 2021.
- Tamarack Advisers opened 39 new positions and closed 11 in Q1 2021.
- Tamarack Advisers's portfolio value rose 1.6% quarter-over-quarter to $488M.
Based on Tamarack Advisers's 13F filing for Q1 2021, filed 12 May 2021.